Publicaciones en colaboración con investigadores/as de Hospital Miguel Servet (24)

2024

  1. Assessing the economic burden of vision loss and irreversible legal blindness in Spain (2021–2030): a societal perspective

    Health Economics Review, Vol. 14, Núm. 1

  2. Author Correction: Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma (Scientific Reports, (2024), 14, 1, (4561), 10.1038/s41598-024-55287-z)

    Scientific Reports

  3. Colour perception develops throughout childhood with increased risk of deficiencies in children born prematurely

    Acta Paediatrica, International Journal of Paediatrics, Vol. 113, Núm. 2, pp. 259-266

  4. Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma

    Scientific Reports, Vol. 14, Núm. 1

  5. Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study

    Eye (Basingstoke)

  6. Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration

    Ophthalmology Retina, Vol. 8, Núm. 4, pp. 350-359

  7. Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice

    Ophthalmology and Therapy, Vol. 13, Núm. 9, pp. 2343-2355

  8. XEN® 45 en el manejo quirúrgico del glaucoma en fases tempranas: estudio nacional de consenso según metodología Delphi

    Archivos de la Sociedad Española de Oftalmologia, Vol. 99, Núm. 3, pp. 98-108

2023

  1. Artificial intelligence-based fluid quantification and associated visual outcomes in a real-world, multicentre neovascular age-related macular degeneration national database

    British Journal of Ophthalmology, Vol. 108, Núm. 2, pp. 253-262

  2. Visual Acuity and Contrast Sensitivity in Preterm and Full-Term Children Using a Novel Digital Test

    Children, Vol. 10, Núm. 1

2022

  1. Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes

    Clinical and Experimental Ophthalmology, Vol. 50, Núm. 3, pp. 312-324

  2. Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry

    Ophthalmology Retina, Vol. 6, Núm. 11, pp. 1044-1053

2021

  1. Author Correction: Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications (Scientific Reports, (2021), 11, 1, (1526), 10.1038/s41598-021-81093-y)

    Scientific Reports

  2. Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications

    Scientific Reports, Vol. 11, Núm. 1

  3. Impacto de la infección por el nuevo coronavirus en los pacientes con uveítis asociada a una enfermedad autoinmune: resultado de la encuesta COVID-19-GEAS pacientes

    Archivos de la Sociedad Española de Oftalmologia, Vol. 96, Núm. 7, pp. 347-352

  4. Multicenter evaluation of time, operational, and economic efficiencies of a new preloaded intraocular lens delivery system versus manual intraocular lens delivery

    Clinical Ophthalmology, Vol. 15, pp. 591-599

  5. Recommendations for ophthalmologic practice during the easing of COVID-19 control measures

    Acta Ophthalmologica, Vol. 99, Núm. 7, pp. e973-e983

2020

  1. Optimization of Diabetic Macular Edema Management in the Real World: A Model of Excellence in Retina Units: The EMUREX Initiative

    Ophthalmologica, Vol. 243, Núm. 5, pp. 379-390

  2. Recomendaciones para la atención oftalmológica durante el estado de alarma por la pandemia de enfermedad por coronavirus COVID-19

    Archivos de la Sociedad Española de Oftalmologia, Vol. 95, Núm. 6, pp. 300-310

2019

  1. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

    Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089